Reszon Diagnostics International Sdn. Bhd.
Reszon Diagnostics International Sdn. Bhd. is a Malaysia-based manufacturer and distributor of IVD rapid test kits (infectious disease, drug of abuse, pregnancy) and point-of-care testing devices, serving healthcare providers, government programs, employers, NGOs and consumers across Southeast Asia, Taiwan and Hong Kong.
- Company typePrivate
- Founded2010
- HeadquartersTaman Universiti, Malaysia
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What Reszon Diagnostics International Sdn. Bhd. does
Reszon Diagnostics International Sdn. Bhd. is a Malaysia-based in vitro diagnostic (IVD) manufacturer and distributor, operating since 2010 as a subsidiary of Hextar Healthcare Berhad with headquarters and primary manufacturing in Subang Jaya, Selangor. The company builds and sells lateral flow immunochromatographic rapid test kits spanning infectious disease (COVID-19, influenza A/B, dengue, hepatitis B and C, HIV, typhoid, filariasis, malaria, brugia), drug of abuse screening (single, combo and cup formats across 24 drug panels), pregnancy detection, and point-of-care testing (POCT) devices including the BIOSYNEX LabPad Evolution platform for CRP, D-Dimer, Fibrinogen and INR. Its proprietary SURE CHECK HIV Self-Test, featuring a patented barrel design requiring only 2.5µL of blood, received FDA Breakthrough Device designation in June 2025 and WHO prequalification, distinguishing it from conventional lateral flow tests.
The company's revenue model is anchored on one-time consumable kit sales and hardware sales of POCT devices with配套 consumables, distributed through a multi-channel architecture spanning direct B2B sales to hospitals, clinics and laboratories, government procurement (Ministry of Health Malaysia, AADK, SPRM, B40 Care Package), pharmacy retail (Alpro Pharmacy, Mega Kulim Pharmacy), NGO partnerships (Malaysian AIDS Council, PT Foundation) for HIV community testing, and exclusive regional distribution of BIOSYNEX products across Southeast Asia, Taiwan and Hong Kong. Products carry ISO 13485:2016 and GDPMD certifications and are sold via quote-based B2B pricing and unit retail pricing with no publicly disclosed price points.
Customer segmentation is verticalised across healthcare providers and clinics, employers and transport operators (TEKAD workplace screening), consumers and at-home users (HIV self-testing via discreet retail and telehealth channels), and government health programs for population screening and outbreak response. Marketing combines content (website, YouTube tutorials, e-newsletter), community engagement (NGO-led World AIDS Day campaigns, university KAMI programs at Universiti Malaya), industry exhibitions and healthcare professional sampling programs. Management includes Katherine Koay as Sales Director; no further leadership details are disclosed.
Reszon Diagnostics International Sdn. Bhd. firmographics
Firmographics- Name
- Reszon Diagnostics International Sdn. Bhd.
- Legal name
- Reszon Diagnostics International Sdn. Bhd.
- Website
- https://reszonics.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Short description
- Reszon Diagnostics International Sdn. Bhd. is a Malaysia-based manufacturer and distributor of IVD rapid test kits (infectious disease, drug of abuse, pregnancy) and point-of-care testing devices, serving healthcare providers, government programs, employers, NGOs and consumers across Southeast Asia, Taiwan and Hong Kong.
- Ownership category
- akta.pro rank
Reszon Diagnostics International Sdn. Bhd. industry classification
Industry- Product category
- In Vitro Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Home-Use & OTC Rapid Self-Tests (Consumer POCT kits) (HLAHAOAK)
- akta.pro secondary industries
- Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK), Point-of-Care & Decentralized Trial Testing Services (HLAGAEAK), Home Diagnostic & Self-Test OTC Kits (HLAIADAO)
Keywords
Where Reszon Diagnostics International Sdn. Bhd. is headquartered
LocationHeadquarters
- HQ city
- Taman Universiti
- HQ country
- Malaysia
- HQ region
- Asia
Offices1 record
Markets served
Reszon Diagnostics International Sdn. Bhd. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Others
Revenue model
- Rapid Diagnostic Test Kits Sales: Manufacture and distribution of IVD rapid test kits for infectious diseases (COVID-19, influenza, dengue, HIV, hepatitis, typhoid, filariasis, malaria), drug of abuse screening, and pregnancy detection. Products sold as one-time purchase consumables through direct sales, distributors, and pharmacy retail channels.
- Point-of-Care Testing Devices: Sale of LabPad Evolution and other POCT devices (Tsmart INR, Ksmart D-DIMER, Ksmart CRP) for professional healthcare settings. Devices sold with配套 consumables and reagents.
- Health Monitoring Devices Distribution: Distribution of health monitoring devices including blood pressure monitors (BEURER BM28), glucometers (FORA 6 Plus), and body composition analyzers (CHARDER U310) from trusted brand partners.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | B2B enterprise and government procurement pricing |
| Unit Pricing | Pay-as-you-go | Pharmacy retail pricing |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels7 records
Reszon Diagnostics International Sdn. Bhd. product offering
Product offeringCore offering
Reszon Diagnostics manufactures and distributes in vitro diagnostic (IVD) rapid test kits covering infectious diseases (COVID-19, influenza A/B, dengue, hepatitis B & C, HIV, syphilis, typhoid, malaria, and filariasis), drug of abuse screening, pregnancy detection, and tropical disease diagnostics. The company also distributes point-of-care testing (POCT) instruments such as the LabPad Evolution and Tsmart/Ksmart modules, alongside partner-brand health monitoring devices (blood pressure monitors, glucometers, body composition analyzers) sold through direct sales, pharmacy chains, NGO partnerships, and an international distributor network spanning ASEAN, Europe, and Africa.
Product overview
Reszon Diagnostics International Sdn. Bhd. is a Malaysia-based manufacturer and distributor of innovative in vitro diagnostic (IVD) rapid test kits and point-of-care testing devices. The product portfolio comprises three main categories: (1) Lateral Flow Rapid Test Kits for infectious disease detection including COVID-19, Influenza, Dengue, Hepatitis B & C, HIV, Typhoid, Filariasis, Malaria, and Brugia; (2) Drug of Abuse (DOA) Rapid Test products in multiple formats (single, combo, cup) with expanded drug and adulterant panels; (3) Point-of-Care Testing (POCT) devices including LabPad Evolution for fibrinogen, INR, D-Dimer, and CRP testing, plus health monitoring devices (blood pressure monitors, glucometers, body composition analyzers) from partner brands. The company also offers pregnancy rapid tests. All products are backed by ISO 13485:2016 quality management system and GDPMD certifications, with distribution through pharmacies, NGOs, and direct channels.
Differentiator
Problem solved
Functional benefit
Brands
- RESZON: Core brand for rapid test kits including HCV, HBsAg, Dengue, Typhoid, Filariasis, Malaria, COVID-19, and Drug of Abuse tests
- SURE CHECK
- Salixium
- RVR
- LabPad Evolution
- HIV 1/2 STAT-PAK
- DPP HIV-Syphilis Assay
- Reszon DOA Rapid
- TESTNOW
Products and services
- RESZON HCV Rapid Test
- RESZON HBsAg Rapid Test
- RESZON ABC Combo Rapid Test
- SALIXIUM COVID-19 Rapid Antigen Test (Oral & Nasal Swab)
- RESZON COVID-19 Rapid Antigen Test (Nasal Swab)
- RESZON COVID-19 Rapid Antigen Test (Saliva)
- RVR Dengue Combo NS1-IgG/IgM Rapid Test
- RVR Dengue IgG/IgM Rapid Test
- RESZON Dengue Rapid Combo NS1 & IgG/IgM
- RESZON Filariasis IgG4 Rapid Test Kit
- RESZON Brugia Rapid Test
- RESZON Typhoid Rapid IgM Test
- RESZON Typhoid Rapid IgG/IgM Combo Test
- Malaria Rapid (Pan/Pf) Test
- SURE CHECK HIV Self-Test
- HIV 1/2 STAT-PAK Assay
- SURE CHECK HIV 1/2 Assay
- DPP HIV-Syphilis Assay
- RESZON DOA Rapid Single Drug Test
- RESZON DOA Rapid Combo Test
- RESZON DOA Rapid Cup Test
- RESZON Pregnancy Rapid Test Midstream
- LabPad Evolution POCT Device
- Tsmart FIB Batrox Test Cartridge
- Tsmart INR Test Cartridge
- Ksmart D-DIMER Test Cartridge
- Ksmart CRP Test Cartridge
- BEURER BM28 Blood Pressure Monitor
- FORA 6 Plus Multi-Functional Monitoring System
- CHARDER U310 Body Composition Analyzer
Quantifiable outcome
- SALIXIUM COVID-19 test sensitivity: 97.24%, specificity: 100%
- +4 more outcomes
Companies that use Reszon Diagnostics International Sdn. Bhd.
Customer profileNamed customers9 records
Segments4 records
Ideal customer profiles4 records
Reszon Diagnostics International Sdn. Bhd. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature5 records
Reszon Diagnostics International Sdn. Bhd. partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- BIOSYNEX (France)coreReszon became the exclusive distributor of BIOSYNEX products for Southeast Asia, Taiwan, and Hong Kong. This partnership drives regional growth in point-of-care testing (POCT) diagnostics, expanding access to LabPad Evolution and other BioSynex products across these markets.
- Chembio Diagnostics, Inc. (USA)coreManufacturing partnership where Chembio produces SURE CHECK HIV Self-Test and HIV 1/2 STAT-PAK Assay, with Reszon serving as exclusive distributor in Malaysia and the region. Chembio's DPP technology platform underpins these products. Reszon contributed RM10,000 as Media Campaign Sponsor and received 1,000 test units as In-Kind Sponsor for World AIDS Day 2024.
- PT FoundationcoreCommunity partnership for HIV prevention outreach and self-testing promotion. PT Foundation provides embedded community access, education, and support in spaces where stigma remains a barrier to testing.
- Malaysian AIDS Council (MAC)coreCollaboration on World AIDS Day exhibitions, community awareness campaigns, and HIV self-testing promotion. Joint sponsorship of RM10,000 as Media Campaign Sponsor plus 1,000 SURE CHECK and 1,000 HIV 1/2 STAT-PAK test kits as In-Kind Sponsor for 2024 World AIDS Day event.
- Klinik Universiti Malaya (UM Clinic)minorUniversity clinic partnership for KAMI (Program Anak Muda IPT) sexual health seminar and HIV awareness program launch. Reszon exhibited HIV rapid test kits to 200 university students and staff.
- Alpro Pharmacy / Alpro One ClickcoreRetail pharmacy distribution partner for SURE CHECK HIV Self-Test. Alpro One Click e-commerce platform enables discreet online purchasing and home delivery of HIV self-test kits.
- Mega Kulim PharmacyminorPharmacy chain distribution partner making HIV self-test kits accessible through retail outlets in Malaysia.
- National Anti-Drugs Agency (AADK)coreSupport for TEKAD (Program Tempat Kerja Bebas Dadah) — national workplace drug-free certification program. AADK leads employer guidelines for drug prevention, intervention, and rehabilitation in government and private sectors.
- Malaysian Anti-Corruption Commission (SPRM)minorCo-signatory with AADK on TEKAD Memorandum of Understanding (2025-2030) for drug-free workplace and integrity initiatives. SPRM reinforces anti-corruption governance within enforcement agencies.
- Addon Supplies (M) Sdn. Bhd. (AOS)minorCo-participant with Reszon and Chembio Diagnostics Malaysia in World AIDS Day 2024 exhibition organized by Malaysian AIDS Council at MyTOWN Shopping Centre.
- Hextar Healthcare BerhadcoreReszon is a subsidiary of Hextar Healthcare Berhad (company registration 201001033978 / 917901-W). Part of the Hextar group of companies providing corporate backing and strategic direction.
- Academic & Research PartnersminorStrategic collaborations with academic and commercial research partners supporting in-house R&D capabilities for immunochromatographic assay development and innovation.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Reszon Diagnostics International Sdn. Bhd. competitors and assessment
Company assessmentDirect peers
- SD Biosensor: South Korea-based manufacturer of lateral flow IVD rapid test kits across infectious disease, cardiac, and DOA categories with strong global public-health footprint. Directly competes with Reszon in COVID-19, influenza, dengue, and other rapid diagnostics sold through government tenders and pharmacy retail across Southeast Asia.
- ACON Laboratories: US-headquartered diagnostics manufacturer with FDA-cleared rapid test portfolio spanning infectious disease, DOA, pregnancy, and urinalysis. Comparable in product breadth and consumer/professional dual-channel distribution model.
- MP Biomedicals: Global life sciences company producing rapid IVD test kits (infectious disease, DOA) alongside research reagents. Comparable rapid diagnostic product set and emerging market distribution model.
- BioSynex: French diagnostics manufacturer of the LabPad Evolution POCT platform and Troponin/INR/D-Dimer rapid tests, of which Reszon is the exclusive distributor across SE Asia/Taiwan/HK. Comparable IVD rapid test portfolio but with broader European distribution and in-house manufacturing.
- CerTest Biotech: Spanish IVD manufacturer producing lateral flow rapid tests for respiratory, gastrointestinal, and tropical infectious diseases. Comparable product portfolio to Reszon's infectious disease and tropical disease lines, with established EU regulatory pathway.
- Chembio Diagnostics: US-based IVD manufacturer of DPP-platform rapid tests (HIV, syphilis, febrile illness) and Reszon's manufacturing partner for SURE CHECK and STAT-PAK HIV assays. Directly comparable technology platform (lateral flow immunoassay) and overlapping HIV self-test product offering.
Emerging players
- Wondfo Biotech: China-based IVD manufacturer with rapid test product lines across infectious disease, fertility, and DOA. Comparable technology platform and price-competitive positioning targeting emerging market distribution channels similar to Reszon's SE Asia strategy.
- Hangzhou AllTest Biotech: Chinese IVD manufacturer focused on lateral flow rapid diagnostic kits across infectious disease, drugs of abuse, cardiac, and fertility categories. Competes directly with Reszon in OEM/private-label rapid test manufacturing and exports to similar emerging-market distribution channels.
Broad incumbents
- Trinity Biotech: Ireland-based diagnostics company with HIV, syphilis, and tropical disease rapid test products plus broader clinical chemistry instruments. Overlaps with Reszon's infectious-disease lateral flow focus but operates as a publicly-listed global incumbent.
- Abbott Rapid Diagnostics: Global IVD leader whose Panbio and BinaxNOW rapid test brands dominate professional and consumer rapid diagnostics worldwide, including COVID-19, influenza, and infectious disease panels. Overlaps with Reszon's product categories but operates at significantly greater scale across far broader geography.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Reszon Diagnostics International Sdn. Bhd. social profiles
Digital presenceReszon Diagnostics International Sdn. Bhd. compliance and trust
Trust signalCompliance4 records
Reszon Diagnostics International Sdn. Bhd. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Reszon Diagnostics International Sdn. Bhd. leadership team
Management profileNumber of profiles
Profiles1 record
Reszon Diagnostics International Sdn. Bhd. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Reszon Diagnostics International Sdn. Bhd. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Reszon Diagnostics International Sdn. Bhd.
What does Reszon Diagnostics International Sdn. Bhd. do?
Reszon Diagnostics manufactures and distributes in vitro diagnostic (IVD) rapid test kits covering infectious diseases (COVID-19, influenza A/B, dengue, hepatitis B & C, HIV, syphilis, typhoid, malaria, and filariasis), drug of abuse screening, pregnancy detection, and tropical disease diagnostics. The company also distributes point-of-care testing (POCT) instruments such as the LabPad Evolution and Tsmart/Ksmart modules, alongside partner-brand health monitoring devices (blood pressure monitors, glucometers, body composition analyzers) sold through direct sales, pharmacy chains, NGO partnerships, and an international distributor network spanning ASEAN, Europe, and Africa.
Is Reszon Diagnostics International Sdn. Bhd. a public or private company?
Reszon Diagnostics International Sdn. Bhd. is a private company. It is classified as corporate owned and is currently operating.
When was Reszon Diagnostics International Sdn. Bhd. founded?
Reszon Diagnostics International Sdn. Bhd. was founded in 2010.
Where is Reszon Diagnostics International Sdn. Bhd. based?
Reszon Diagnostics International Sdn. Bhd. is headquartered in Taman Universiti, Malaysia, in the Asia region.
How does Reszon Diagnostics International Sdn. Bhd. make money?
Three revenue lines are on record. Rapid Diagnostic Test Kits Sales are the primary driver. The others are point-of-Care Testing Devices and health Monitoring Devices Distribution.
Who are Reszon Diagnostics International Sdn. Bhd.'s main competitors?
Direct peers on record are SD Biosensor, ACON Laboratories, MP Biomedicals, BioSynex, CerTest Biotech and Chembio Diagnostics. Emerging players are Wondfo Biotech and Hangzhou AllTest Biotech. Broad incumbents are Trinity Biotech and Abbott Rapid Diagnostics.
Does Reszon Diagnostics International Sdn. Bhd. have an API?
No public API is recorded for Reszon Diagnostics International Sdn. Bhd..
What industry is Reszon Diagnostics International Sdn. Bhd. in?
Reszon Diagnostics International Sdn. Bhd.'s product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAHAOAK, Home-Use & OTC Rapid Self-Tests (Consumer POCT kits), with a secondary code of CRADAMAK, Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests). Its NAICS code is 325413 and its SIC code is 2835.